择期EVAR术后1a型内漏的长期结局与干预
发生PT1a者女性比例更高、全因死亡与动脉瘤相关死亡更高,中位出现时间为52个月。接受干预并内漏消除者中位生存与其余EVAR队列无显著差异。
要点
- EVAR术后PT1a发生率8.2%,中位52个月出现,需长期影像随访。
- PT1a与全因死亡(71% vs 40%)及动脉瘤相关死亡(15.6% vs 1.7%)升高相关。
- 干预后80.7%内漏消除,消除者中位生存与总体队列无显著差异。
核心结论
- 择期EVAR后发生PT1a与全因死亡和动脉瘤相关死亡升高相关,中位术后52个月出现,凸显长期监测的重要性。
- PT1a接受成功干预者中位生存与其余EVAR队列无显著差异。
- 合并iT1a者发生PT1a风险更高、中位生存下降,但无已知动脉瘤相关死亡。
研究设计与样本
- PT1a患者32例,中位随访74个月(IQR 52-138个月),与未发生PT1a者比较。
- 另分析PT1a中术中完成造影存在iT1a、初次随访影像已消失的亚组。
主要发现
- PT1a发生率为8.2%(n=32),中位出现时间52个月。
- PT1a组女性占32% vs 17%(P=.03),全因死亡71% vs 40%(P<.01),动脉瘤相关死亡15.6% vs 1.7%(P<.01)。
- 32例PT1a中5例(15.6%)以主动脉破裂就诊,6例(18.7%)拒绝干预。
- 26例接受干预者中21例(80.7%)PT1a消除,5例(19.2%)复发。
- PT1a干预后消除者中位生存估计140.0个月,其余EVAR队列120.0个月(P=.80)。
关键数值与推荐
- PT1a组6例(18.7%)合并iT1a,晚期PT1a平均出现时间45个月。
- iT1a与PT1a发生风险显著升高相关(P<.01),与中位生存下降相关(P<.01)。
- 复发PT1a 5例中2例发生动脉瘤相关死亡,2例再置入支架后内漏消除,1例拒绝干预仍存活。
临床怎么用
- 择期EVAR后应坚持长期影像监测,关注术后数十个月内新发1a型内漏。
- 对PT1a应积极评估干预,成功消除内漏者生存与总体EVAR队列相近。
- 术中iT1a即使初次随访消失仍属高危,需更密切随访。
局限性
- 单中心回顾性设计,样本量有限(PT1a仅32例),部分亚组事件数少。
- 部分患者拒绝干预,干预与否存在选择偏倚,生存比较为非随机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study evaluated the incidence and long-term outcomes of postoperative type 1a endoleak (PT1a) following endovascular aortic aneurysm repair (EVAR). METHODS: A retrospective review of consecutive aortoiliac EVARs performed at a single institution from June 2006 to June 2012 was conducted. Patients with PT1a were identified by postoperative imaging and compared with those who did not develop a PT1a. Late outcomes were also studied of a subset of patients with PT1a who had persistent intraoperative type 1a endoleak (iT1a) on completion angiogram during EVAR that had resolved on initial follow-up imaging. RESULTS: Three hundred eighty-nine patients underwent EVAR with median follow-up of 87 months (interquartile range, 64-111 months). The incidence of PT1a was 8.2% (n = 32) with a median follow-up of 74 months (interquartile range, 52-138 months). Compared with the total cohort, those who developed PT1a were statistically more likely to be female (32% vs 17%; P = .03) and have a higher all-cause mortality (71% vs 40%; P < .01) and aneurysm-related mortality (15.6% vs 1.7%; P < .01). Median time to presentation was 52 months. Of the 32 patients with PT1a, five (15.6%) presented with aortic rupture, of which three underwent extension cuff placement, one had open graft explant, and one declined intervention. Six patients in total (18.7%) declined intervention; five of these died of nonaneurysmal causes and one remains alive. Of the 26 patients with PT1a who had intervention, 21 (80.7%) showed resolution of PT1a, and five (19.2%) had recurrence. For patients with recurrent PT1a, two had resulting aneurysm-related mortality, two endoleaks resolved after relining with an endograft, and one patient declined intervention but remains alive. Patients with PT1a who had intervention with resolution showed no significant difference in median survival estimates (140.0 months) compared with the remaining EVAR cohort (120.0 months; P = .80). Within the PT1a cohort, 6 (18.7%) had also experienced iT1a with a mean time to presentation of the late PT1a of 45 months. iT1a was associated with a significantly increased likelihood of developing a PT1a (P < .01) and decreased median survival (P < .01), but there was no known aneurysm-related mortality. CONCLUSIONS: Development of PT1a following elective EVAR is associated with increased all-cause and aneurysm-related mortality and presents an average of 52 months postoperatively. This underscores the importance of long-term surveillance. Patients with PT1a who had a successful intervention showed no significant difference in median survival. Those with iT1a had a higher risk for PT1a compared with the EVAR cohort overall and had decreased median survival, without increased aneurysm-related mortality.
引用
- Major M, Long GW, Eden CL, et al. Long-term outcomes and interventions of postoperative type 1a endoleak following elective endovascular aortic aneurysm repair. J Vasc Surg. 2021. PMID: 34324969. doi:10.1016/j.jvs.2021.07.122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。